Prevalence of uncontrolled hypertension and its associated factors in 50-74 years old Iranian adults: a population-based study
Although the research is promising, there are many factors that could potentially impact depression among people with obesity who are taking these medications (weight loss, physical activity, less medical burden, nutritional status, hopefulness, sleep, etc). Semaglutide and tirzepatide were the two medications most strongly related to decreased risk of depression and anxiety
The data shows tirzepatide producing weight reduction of 17.60 kg compared to semaglutide at 11.85 kg, a difference of nearly 6 kilograms
Step 5: Achieve and Maintain Your Goals Once you reach your target weight, your provider will help you transition to a maintenance plan
Intermittent or reduced-dose strategies lack robust clinical trial support and may result in partial benefit loss